Tissue Inhibitor of Metalloproteinases
-
Subject Areas on Research
- A blood-based biomarker panel to detect acute stroke.
- Catalytic properties of ADAM12 and its domain deletion mutants.
- Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort.
- Developmental expression of tissue inhibitor of metalloproteinase (TIMP) RNA.
- Engraftment of human synovium into severe combined immune deficient mice. Migration of human peripheral blood T cells to engrafted human synovium and to mouse lymph nodes.
- Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling.
- Expression of TIMP in fetal and adult mouse tissues studied by in situ hybridization.
- Expression of genes for non-collagenous proteins during embryonic bone formation.
- HIV-1 infection stimulates T cell invasiveness and synthesis of the 92-kDa type IV collagenase.
- Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
- Matrix Metalloproteinases and Glaucoma Treatment.
- Matrix metalloproteinases and their inhibitors in human vitreous.
- Plasma biomarkers for distinguishing etiologic subtypes of thoracic aortic aneurysm disease.
- Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.
- Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling.
- Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes.
- The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10.